HOB Biotech Gross Profit vs. Price To Sales
| 688656 Stock | 101.27 0.96 0.94% |
Gross Profit | First Reported 2019-03-31 | Previous Quarter 53.1 M | Current Value 75.8 M | Quarterly Volatility 14.4 M |
For HOB Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HOB Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HOB Biotech Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HOB Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HOB Biotech Group over time as well as its relative position and ranking within its peers.
HOB |
HOB Biotech Group Price To Sales vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining HOB Biotech's current stock value. Our valuation model uses many indicators to compare HOB Biotech value to that of its competitors to determine the firm's financial worth. HOB Biotech Group is number one stock in gross profit category among its peers. It also is number one stock in price to sales category among its peers . The ratio of Gross Profit to Price To Sales for HOB Biotech Group is about 20,484,640 . At present, HOB Biotech's Gross Profit is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value HOB Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HOB Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.HOB Price To Sales vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
HOB Biotech |
| = | 320.16 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
HOB Biotech |
| = | 15.63 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
HOB Price To Sales Comparison
HOB Biotech is currently under evaluation in price to sales category among its peers.
HOB Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in HOB Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, HOB Biotech will eventually generate negative long term returns. The profitability progress is the general direction of HOB Biotech's change in net profit over the period of time. It can combine multiple indicators of HOB Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 55.2 M | 59.4 M | |
| Income Before Tax | 56.6 M | 57.3 M | |
| Total Other Income Expense Net | -1.3 M | -1.3 M | |
| Net Income | 47.9 M | 49.8 M | |
| Income Tax Expense | 5.6 M | 7.2 M | |
| Net Interest Income | -1.2 M | -1.2 M | |
| Interest Income | 1.6 M | 1 M | |
| Net Income From Continuing Ops | 47.3 M | 47.3 M |
HOB Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on HOB Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HOB Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HOB Biotech's important profitability drivers and their relationship over time.
Use HOB Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HOB Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HOB Biotech will appreciate offsetting losses from the drop in the long position's value.HOB Biotech Pair Trading
HOB Biotech Group Pair Trading Analysis
The ability to find closely correlated positions to HOB Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HOB Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HOB Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HOB Biotech Group to buy it.
The correlation of HOB Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HOB Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HOB Biotech Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HOB Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your HOB Biotech position
In addition to having HOB Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in HOB Stock
To fully project HOB Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of HOB Biotech Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include HOB Biotech's income statement, its balance sheet, and the statement of cash flows.